Nu Med Plus Stock Technical Analysis
| NUMD Stock | USD 0.01 0.01 29.00% |
As of the 2nd of February, Nu-Med Plus owns the Mean Deviation of 3.38, market risk adjusted performance of (0.45), and Information Ratio of (0.1). In relation to fundamental indicators, the technical analysis model lets you check practical technical drivers of Nu Med Plus, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We have collected data for twelve technical drivers for Nu-Med Plus, which can be compared to its peers in the sector. Please verify Nu Med Plus market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Nu Med Plus is priced correctly, providing market reflects its prevailing price of 0.0142 per share. As Nu Med Plus appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.
Nu-Med Plus Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Nu-Med, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Nu-MedNu-Med |
Nu-Med Plus 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nu-Med Plus' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nu-Med Plus.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Nu-Med Plus on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Nu Med Plus or generate 0.0% return on investment in Nu-Med Plus over 90 days. Nu-Med Plus is related to or competes with Talis Biomedical, USA Equities, and Kelyniam Global. Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of m... More
Nu-Med Plus Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nu-Med Plus' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nu Med Plus upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 55.96 | |||
| Value At Risk | (13.33) |
Nu-Med Plus Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nu-Med Plus' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nu-Med Plus' standard deviation. In reality, there are many statistical measures that can use Nu-Med Plus historical prices to predict the future Nu-Med Plus' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.86) | |||
| Total Risk Alpha | (1.20) | |||
| Treynor Ratio | (0.46) |
Nu-Med Plus February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.45) | |||
| Mean Deviation | 3.38 | |||
| Coefficient Of Variation | (1,070) | |||
| Standard Deviation | 8.42 | |||
| Variance | 70.86 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.86) | |||
| Total Risk Alpha | (1.20) | |||
| Treynor Ratio | (0.46) | |||
| Maximum Drawdown | 55.96 | |||
| Value At Risk | (13.33) | |||
| Skewness | 1.48 | |||
| Kurtosis | 14.64 |
Nu Med Plus Backtested Returns
Nu Med Plus retains Efficiency (Sharpe Ratio) of -0.0956, which conveys that the firm had a -0.0956 % return per unit of price deviation over the last 3 months. Nu-Med Plus exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nu-Med Plus' Market Risk Adjusted Performance of (0.45), information ratio of (0.1), and Mean Deviation of 3.38 to check out the risk estimate we provide. The company owns a Beta (Systematic Risk) of 1.72, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nu-Med Plus will likely underperform. At this point, Nu Med Plus has a negative expected return of -0.82%. Please make sure to verify Nu-Med Plus' variance and the relationship between the value at risk and relative strength index , to decide if Nu Med Plus performance from the past will be repeated at future time.
Auto-correlation | -0.21 |
Weak reverse predictability
Nu Med Plus has weak reverse predictability. Overlapping area represents the amount of predictability between Nu-Med Plus time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nu Med Plus price movement. The serial correlation of -0.21 indicates that over 21.0% of current Nu-Med Plus price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Nu-Med Plus technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Nu Med Plus Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Nu Med Plus volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Nu-Med Plus Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Nu Med Plus on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Nu Med Plus based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Nu Med Plus price pattern first instead of the macroeconomic environment surrounding Nu Med Plus. By analyzing Nu-Med Plus's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Nu-Med Plus's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Nu-Med Plus specific price patterns or momentum indicators. Please read more on our technical analysis page.
Nu-Med Plus February 2, 2026 Technical Indicators
Most technical analysis of Nu-Med help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Nu-Med from various momentum indicators to cycle indicators. When you analyze Nu-Med charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.45) | |||
| Mean Deviation | 3.38 | |||
| Coefficient Of Variation | (1,070) | |||
| Standard Deviation | 8.42 | |||
| Variance | 70.86 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.86) | |||
| Total Risk Alpha | (1.20) | |||
| Treynor Ratio | (0.46) | |||
| Maximum Drawdown | 55.96 | |||
| Value At Risk | (13.33) | |||
| Skewness | 1.48 | |||
| Kurtosis | 14.64 |
Nu-Med Plus February 2, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Nu-Med stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.71 | ||
| Day Median Price | 0.01 | ||
| Day Typical Price | 0.01 | ||
| Price Action Indicator | 0.00 |
Complementary Tools for Nu-Med OTC Stock analysis
When running Nu-Med Plus' price analysis, check to measure Nu-Med Plus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu-Med Plus is operating at the current time. Most of Nu-Med Plus' value examination focuses on studying past and present price action to predict the probability of Nu-Med Plus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu-Med Plus' price. Additionally, you may evaluate how the addition of Nu-Med Plus to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |